Cascadian Therapeutics
Cascadian engages in the development of oncology products for the treatment of cancer.
Business Model:
Revenue: $145k
Employees: 51-200
Rankings
Industries / Tags:
Detailed Cascadian Therapeutics Information
Cascadian Therapeutics was acquired by
Seagen.
The acquisition happend on 2018-01-31.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 2601 4th Ave Ste 500
City: Seattle
State: WA
Zip: 98121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$65M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cascadian engages in the development of oncology products for the treatment of cancer.
Contact Phone:
+12068012100
Contact Email:
Cascadian Therapeutics went public on 11/29/1991 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/29/1991
Ticker Symbol:
ONTY
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 8/2014 | Alpine Biosciences | |
| 10/2006 | ProlX Pharmaceuticals Corp. |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
